Pefloxacin versus levofloxacin in the treatment efficacy evaluation of lower respiratory tract infection.doc

 PAGE \* MERGEFORMAT 8 Pefloxacin versus levofloxacin in the treatment efficacy evaluation of lower respiratory tract infection [Abstract] Objective: To compare the Pefloxacin and Ofloxacin in the treatment of lower respiratory tract infection efficacy, adverse reactions. Methods: 117 patients with lower respiratory tract infection were divided into two groups: Pefloxacin treatment group 60 cases, 0.4 g 2 times / d, intravenous drip, levofloxacin treatment group, 57 cases, 0.3 g 2 times / d, intravenous drip, course of treatment are 7 d ~ 14 d. Results: pefloxacin and levofloxacin in the treatment of lower respiratory tract infection efficiency was 90.0% and 87.5%, cure rates were 76.8% and 77.2%, no significant difference. Conclusion: pefloxacin and levofloxacin in the treatment of lower respiratory tract infection is similar to the clinical effect and adverse reactions. [Keywords:] Pefloxacin; levofloxacin; lower respiratory tract infection Evaluation Levofloxacin and Pefloxacin Treatment Subrespistory Tract Infection Effects Abstract: Objective To stuy effective, side effective of levofloxacin and pefloxacinto cure subrespistory tract infection.Methods 117 patients were randonmly divided into two groups (60 samples) was given pefloxacin 0.4g iv bid 7 ~ 14 days.another group (57 samples) was given levofloxacin 0.3g, iv bid 7 ~ 14 days. Results The total response rate oflevofloxacin and pefloxacin were 87.7%, 90.0%, the total cure rate of levofloxacin and pefloxacin were, 77.2%, 76.8%. ther was no significant difference. Conclusion Effects side of levofloxacin and pefloxacin in treating subrespistory tract infection were simlar. Keywords:: Pefloxacin; Levofloxacin; Subrespistory Lower respiratory tract bacterial infections (community-acquired and hospital-acquired) in the clinical is common and frequently-occurring disease, particularly in hospital-acquired lower respiratory tract infection. In recent years, morbidity and mortality of the upw